PHI with Birch pollen allergy
How does this condition affect your private health insurance?
Birkenpollenallergie, or birch pollen allergy, is a common seasonal allergic rhinitis triggered by airborne pollen from birch trees. It typically manifests with symptoms like sneezing, runny or stuffy nose, itchy eyes, and an irritated throat. In some individuals, it can also lead to more severe symptoms such as allergic asthma. It often occurs during spring (March to May) when birch trees release their pollen. The immune system mistakenly identifies the harmless pollen proteins as a threat, releasing histamines and other chemicals that cause the allergic reaction. This allergy can significantly impair quality of life during its season, affecting sleep, concentration, and daily activities. Cross-reactivity with certain fruits and vegetables (oral allergy syndrome) is also common.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks during the pollen season (typically March-May)
Duration of Illness (Lifetime)
Chronic, seasonal recurrence, often for many years or a lifetime
Cost of Treatment (Initial)
Low to moderate (e.g., 20-100 EUR/USD for over-the-counter medication per season)
Cost of Treatment (Lifetime)
Moderate to high (e.g., hundreds to thousands EUR/USD over a lifetime for symptomatic relief or immunotherapy)
Mortality Rate
Extremely low (near 0%)
Risk of Secondary Damages
Moderate (e.g., development of allergic asthma, chronic sinusitis, oral allergy syndrome, impaired quality of life)
Probability of Full Recovery
Low for spontaneous recovery; moderate with allergen-specific immunotherapy (desensitization)
Underlying Disease Risk
Moderate (e.g., higher likelihood of developing asthma, other allergic rhinitis, or eczema)